GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients

Experimental and Therapeutic Medicine

Volumn 4, Issue 6, 2012, Pages 1097-1103

  Saxena, Anubha ^a,b   Dhillon, Varinderpal S ^c   Shahid, Mohammad ^a,d,e   Khalil, Hesham Saleh ^f   Rani, Madhu ^g   Das, Trinath Prasad ^g   Hedau, Suresh ^h   Hussain, Arif ⁱ   Naqvi, Raza Ali ^a   Deo, S V S ^j   Shukla, N K ^j   Das, B C ^h   Husain, Syed Akhtar ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b DE DUVE INSTITUTE   (Belgium)

^c CSIRO   (Australia)

^d Department of Oral and Maxillofacial Surgery and Diagnostic Science   (Saudi Arabia)

^e PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

^g JAWAHARLAL NEHRU UNIVERSITY   (India)

^h INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

ⁱ Manipal University   (United Arab Emirates)

^j INSTITUTE ROTARY CANCER HOSPITAL   (India)

more..

Author keywords

Expression; GSTP1; Methylation; Polymorphism

Indexed keywords

ESTROGEN RECEPTOR; GLUTATHIONE TRANSFERASE P1; PROGESTERONE RECEPTOR; VALINE;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIET; DNA METHYLATION; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; GSTP1 GENE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIFESTYLE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TUMOR BIOPSY; WESTERN BLOTTING;

EID: 84867263824     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.710     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Widschwendter M and Jones PA: DNA methylation and breast carcinogenesis. Oncogene 21: 5462-5482, 2002.
3. Pongtheerat T, Pakdeethai S, Purisa W, Chariyalertsak S and Petmitr S: Promoter methylation and genetic polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai breast-cancer patients. Asian Pac J Cancer Prev 12: 2731-2734, 2011
4. Lu S, Wang Z, Cui D, Liu H and Hao X: Glutathione Stransferase P1 Ile105Val polymorphism and breast cancer risk: a metaanalysis involving 34,658 subjects. Breast Cancer Res Treat 125: 253-259, 2011.
5. Jones PA and Baylin SB: The epigenomics of cancer. Cell 128: 683-692, 2007.
6. Fraga MF, Herranz M, Espada J, et al: A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumours. Cancer Res 64: 5527-5534, 2004.
7. Esteller M: Epigenetics in cancer. N Eng J Med 358: 1148-1159, 2008.
8. Silvestrini R, Veneroni S, Benini E, et al: Expression of p53 glutathione S-transferase-pi and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst 89: 639-645, 1997.
9. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB and Herman JG: Inactivation of glutathione Stransferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58: 4515-4518, 1998.
10. Lee JS: GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch 450: 637-642, 2007.
11. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL and Clark SJ: Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 18: 1313-1324, 1999.
12. Jerónimo C, Varzim G, Henrique R, et al: I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 11: 445-450, 2002.
13. Chan QK, Khoo US, Chan KY, et al: Promoter methylation and differential expression of piclass glutathione S-transferase in endometrial carcinoma. J Mol Diagn 7: 8-16, 2005.
14. Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI and Sidransky D: Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. Clin Cancer Res 10: 5518-5522, 2004.
15. Zhong S, Tang MW, Yeo W, Liu C, Lo YM and Johnson PJ: Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin Cancer Res 8: 1087-1092, 2002.
16. Arai T, Miyoshi Y, Kim SJ, Taguchi T, Tamaki Y and Noguchi S: Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 100: 169-176, 2006.
17. Hoque MO, Feng Q, Toure P, et al: Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24: 4262-4269, 2006.
18. Parrella P, Poeta ML, Gallo AP, et al: Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res 10: 5349-5354, 2004.
19. Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R and Taback B: Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Clin Cancer Res 11: 2156-2162, 2005.
20. Henderson CJ, McLaren AW, Moffat GJ, Bacon EJ and Wolf CR: Pi-class glutathione S-transferase: regulation and function. Chem Biol Interact 111-112: 69-82, 1998.
21. Hu X, Xia H, Srivastava SK, Pal A, Awasthi YC, Zimniak P and Singh SV: Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene. Cancer Res 58: 5340-5343, 1998.
22. Antognelli C, Del Buono C, Ludovini V, Gori S, Talesa VN, Crinò L, Barberini F and Rulli A: CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study. BMC Cancer 9: 115, 2009.
23. Reding KW, Weiss NS, Chen C, et al: Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18: 1461-1467, 2009.
24. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk: Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119: 463-474, 2010.
25. Saxena A, Dhillon VS, Raish M, et al: Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res Treat 115: 537-543, 2009.
26. Zhang BL, Sun T, Zhang BN, et al: Polymorphisms of GSTP1 is associated with differences of chemotherapy response and toxicity in breast cancer. Chin Med J (Engl) 124: 199-204, 2011.
27. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636, 2002.
28. Sobin LH and Fleming ID: TNM classification of Malignant Tumors, 5th edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997.
29. Strange RC, Spiteri MA, Ramachandran S and Fryer AA: Glutathione-S-transferase family of enzymes. Mutat Res 482: 21-26, 2001.
30. Kopps S, Angeli-Greaves M, Blaszkewicz M, et al: Glutathione S-transfrease P1 Ile105Val polymoprphism in occupationally exposed bladder cancer cases. J Toxicol Environ Health A 71: 898-901, 2008.
31. Bernardini S, Bellincampi L, Ballerini S, et al: Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin Chem 51: 944-951, 2005.
32. Johansson AS, Stenberg G, Widersten M and Mannervik B: Structure activity relationships and thermal stability of human glutathione transferase P1-1 governed by the H-site residue 105. J Mol Biol 278: 687-698, 1998.
33. Baylin SB, Belinsky SA and Herman JG: Aberrant methylation of gene promoters in cancer - concepts, misconcepts, and promise. J Natl Cancer Inst 92: 1460-1461, 2000.
34. Gazzoli I, Loda M, Garber J, Syngal S and Kolodner RD: A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 62: 3925-3928, 2002.
35. Adler V, Yin Z, Fuchs SY, et al: Regulation of JNK signaling by GSTp. EMBO J 18: 1321-1334, 1999.
36. Kinzler KW and Vogelstein B: Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761-763, 1997.
37. Lee WH, Morton RA, Epstein JI, et al: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 11733-11737, 1994.
38. Brooks JD, Weinstein M, Lin X, et al: CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomark Prev 7: 531-536, 1998.
39. Tserga A, Michalopoulos NV, Levidou G, Korkolopoulou P, Zografos G, Patsouris E and Saetta AA: Association of aberrant DNA methylation with clinicopathological features in breast cancer. Oncol Rep 27: 1630-1638, 2012.
40. Matuschek C, Bölke E, Lammering G, et al: Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. Eur J Med Res 15: 277-286, 2010.
41. Fishman J, Osborne MP and Telang NT: The role of estrogen in mammary carcinogenesis. Ann NY Acad Sci 768: 91-100, 1995.
42. Cavalieri EL, Stack DE, Devanesan PD, et al: Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 94: 10937-10942, 1997.
43. Lee JS, Lo PK, Fackler MJ, Argani P, Zhang Z, Garret-tMeyer E and Sukumar S: A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women. Cancer Biol Ther 6: 1114-1120, 2007.
44. Cho YH, Shen J, Gammon MD, Zhang YJ, et al: Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat 131: 197-205, 2012.